Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Jan 18, 2016

5262_dirs_2016-01-18_5d5e5ca7-846e-439e-ba68-97ad50287468.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1557M

GlaxoSmithKline PLC

18 January 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc ('GSK') was advised on 18 January 2016 that the following acquisitions of GSK Ordinary shares took place on 15 January 2016, at a price of 1377.50 pence per Ordinary share, following the re-investment of the dividend paid to shareholders on 14 January 2016, on shares held within an ISA:

Director/PDMR Number of Ordinary shares
Sir Andrew Witty 152
Mr D S Redfern 23
Mrs V A Whyte 19
Connected Person Number of Ordinary shares
Lady C Witty (Connected Person of Sir Andrew Witty) 39

V A Whyte

Company Secretary

18 January 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBVLFFQFFZBBE